Have a feature idea you'd love to see implemented?
Let us know!
ACHV Achieve Life Sciences Inc.
Price (delayed)
$4.33
Market cap
$148.91M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$1.11
Enterprise value
$149.21M
Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company, develops and commercializes of cytisinicline for smoking cessation and nicotine addiction in Canada, the United States, and the United Kingdom. The company
Highlights
Achieve Life Sciences's EPS has increased by 45% YoY
The debt has contracted by 44% from the previous quarter and by 40% YoY
ACHV's net income is down by 20% QoQ but it is up by 7% YoY
Achieve Life Sciences's equity has decreased by 26% QoQ
Key stats
What are the main financial stats of ACHV
Market
Valuations
Earnings
Shares outstanding
34.39M
Market cap
$148.91M
Enterprise value
$149.21M
Price to earnings (P/E)
N/A
Price to book (P/B)
4.74
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
EBIT
-$30.17M
EBITDA
-$29.95M
Free cash flow
-$24.95M
Per share
Balance sheet
Liquidity
EPS
-$1.11
Free cash flow per share
-$0.73
Book value per share
$0.91
Revenue per share
$0
TBVPS
$1.33
Total assets
$47.92M
Total liabilities
$16.54M
Debt
$9.85M
Equity
$31.38M
Working capital
$38.81M
Debt to equity
0.31
Current ratio
6.78
Quick ratio
6.39
Net debt/EBITDA
-0.01
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-65.2%
Return on equity
-108.3%
Return on invested capital
-138.9%
Return on capital employed
-73.2%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
ACHV stock price
How has the Achieve Life Sciences stock price performed over time
Intraday
0.58%
1 week
-1.37%
1 month
-13.05%
1 year
-17.84%
YTD
5.1%
QTD
-8.65%
Financial performance
How have Achieve Life Sciences's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$31.27M
Net income
-$32.94M
Gross margin
N/A
Net margin
N/A
Achieve Life Sciences's operating income has decreased by 23% QoQ but it has increased by 7% YoY
ACHV's net income is down by 20% QoQ but it is up by 7% YoY
Growth
What is Achieve Life Sciences's growth rate over time
Valuation
What is Achieve Life Sciences stock price valuation
P/E
N/A
P/B
4.74
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Achieve Life Sciences's EPS has increased by 45% YoY
The P/B is 76% less than the 5-year quarterly average of 19.6
Achieve Life Sciences's equity has decreased by 26% QoQ
Efficiency
How efficient is Achieve Life Sciences business performance
Achieve Life Sciences's return on equity has surged by 83% YoY and by 7% QoQ
Achieve Life Sciences's return on invested capital has surged by 75% YoY and by 12% QoQ
ACHV's ROA has soared by 52% year-on-year but it is down by 6% since the previous quarter
Dividends
What is ACHV's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for ACHV.
Financial health
How did Achieve Life Sciences financials performed over time
The total assets is 190% more than the total liabilities
The total assets has soared by 97% YoY but it has contracted by 26% from the previous quarter
ACHV's current ratio is up by 49% since the previous quarter and by 26% year-on-year
The debt is 69% less than the equity
Achieve Life Sciences's debt to equity has plunged by 92% YoY and by 26% from the previous quarter
The debt has contracted by 44% from the previous quarter and by 40% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.